Iran to keep drug import restrictions after nuclear deal
Tehran, Iran, June 14
By Mehdi Sepahvand - Trend:
Iran will keep its limitation of drug imports even after a nuclear deal is struck and sanctions removed, Director General of the Drug Assessment office of the Food and Drug Organization Mahdi Pirsalehi said.
The official pointed out that Iran has boosted the domestic production of drugs, ISNA news agency reported June 14.
He mentioned that as there will not be much difference in the drug-importing companies in the pre and post-nuclear deal eras, the restriction policies will remain in place after sanctions on the Iranian economy are removed.
Iran is negotiating with the group P5+1 (the US, UK, France, Russia, China, and Germany) to arrive at a nuclear agreement whereby sanctions on its economy will be lifted.
Pirsalehi noted that the restrictions are posed to help domestic production. He stated that 97 percent of the drugs used in Iran are made inside the country.
However, to meet demands, the import of drugs not produced in the country is permitted, he said.